Carl Zeiss Licences Digital Pathology from Olympus

17-07-2012: Carl Zeiss Microscopy GmbH and Olympus America Inc. have signed a nonexclusive worldwide licensing agreement allowing Carl Zeiss to access an extensive portfolio of patents held by Olympus in the field of digital pathology and virtual microscopy. The patents included in the licensing deal cover methods and equipment for creating, storing and delivering virtual microscopy slides. The technology enables individuals to view and share high-resolution virtual microscopy images over the Internet.

"The handling of digital data has become a major driver of the development of modern microscopy,” said Dr. Bernhard Ohnesorge, Member of the Board and General Manager BioSciences Division of Carl Zeiss Microscopy. “Integrating the virtual slide functionality into our research microscope systems will enable our customers to become more efficient and to explore new scientific approaches. This will help them to better understand the root causes of the most challenging diseases.”

“Global adoption of digital slide scanning continues to expand into new medical and scientific applications,” said Brad Burklow, Executive Director Business Development, Scientific Equipment Group, Olympus Corporation of the Americas. “Olympus is the holder of many important patents in this area, and we feel it is vital to allow broad access to these technologies in order to advance the field of pathology and medical research. We are confident that leveraging these technologies will enhance healthcare for patients around the world.”

The companies are not making specific terms and conditions of the agreement public.

Facts, background information, dossiers
More about Carl Zeiss
  • News

    Zeiss receives ISO 9001 quality management system certification

    Carl Zeiss Microscopy, LLC announces that it has received ISO 9001:2008 quality management system certification for product marketing, sales, service and support for its high precision optomechanical instruments. The ISO 9001 certification attests to ZEISS’ commitment to implementing best b ... more

    ZEISS broadens portfolio of intraocular lenses

    Carl Zeiss Meditec AG announces it has acquired, through its subsidiary Carl Zeiss Meditec Inc., 100% of the shares in Aaren Scientific Inc., a US-based manufacturer of intraocular lenses (IOLs). Aaren Scientific, headquartered in Ontario, California, has been manufacturing IOLs for more th ... more

    ZEISS ends successful fiscal year 2012/13

    ZEISS has brought fiscal year 2012/13 to a successful conclusion with an all-time high in revenue. The company put in a good performance in some sectors despite a partly difficult economic environment and generated revenue totaling EUR 4.190 billion (prior year: EUR 4.163 billion) and earni ... more

More about Olympus
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE